» Articles » PMID: 27806107

Role of Patient and Practice Characteristics in Variance of Treatment Quality in Type 2 Diabetes Between General Practices

Overview
Journal PLoS One
Date 2016 Nov 3
PMID 27806107
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Accounting for justifiable variance is important for fair comparisons of treatment quality. The variance between general practices in treatment quality of type 2 diabetes (T2DM) patients may be attributed to the underlying patient population and practice characteristics. The objective of this study is to describe the between practice differences in treatment, and identify patient and practice level characteristics that may explain these differences.

Methods: The data of 24,607 T2DM patients from 183 general practices in the Netherlands were used. Treatment variance was assessed in a cross-sectional manner for: glucose-lowering drugs/metformin, lipid-lowering drugs/statins, blood pressure-lowering drugs/ACE-inhibitor or ARB. Patient characteristics tested were age, gender, diabetes duration, comorbidity, comedication. Practice characteristics were number of T2DM patients, practice type, diabetes assistant available. Multilevel logistic regression was used to examine the between practice variance in treatment and the effect of characteristics on this variance.

Results: Treatment rates varied considerably between practices (IQR 9.5-13.9). The variance at practice level was 7.5% for glucose-lowering drugs, 3.6% for metformin, 3.1% for lipid-lowering drugs, 10.3% for statins, 8.6% for blood pressure-lowering drugs, and 3.9% for ACE-inhibitor/ARB. Patient and practice characteristics explained 19.0%, 7.5%, 20%, 6%, 9.9%, and 13.4% of the variance respectively. Age, multiple chronic drugs, and ≥3 glucose-lowering drugs were the most relevant patient characteristics. Number of T2DM patients per practice was the most relevant practice characteristic.

Discussion: Considerable differences exist between practices in treatment rates. Patients' age was identified as characteristic that may account for justifiable differences in especially lipid-lowering treatment. Other patient or practice characteristics either do not explain or do not justify the differences.

Citing Articles

Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.

Quigley M, Earnest A, Szwarcbard N, Wischer N, Andrikopoulos S, Green S PLoS One. 2022; 17(2):e0263511.

PMID: 35120182 PMC: 8815864. DOI: 10.1371/journal.pone.0263511.


Predictors of potentially suboptimal treatment of urinary tract infections in long-term care facilities.

Appaneal H, Caffrey A, Lopes V, Mor V, Dosa D, LaPlante K J Hosp Infect. 2021; 110:114-121.

PMID: 33549769 PMC: 8045483. DOI: 10.1016/j.jhin.2021.01.019.


Changes in blood pressure thresholds for initiating antihypertensive medication in patients with diabetes: a repeated cross-sectional study focusing on the impact of age and frailty.

Ambroz M, de Vries S, Sidorenkov G, Hoogenberg K, Denig P BMJ Open. 2020; 10(9):e037694.

PMID: 32912988 PMC: 7485238. DOI: 10.1136/bmjopen-2020-037694.


Using Electronic Health Record Activity to Represent Interdisciplinary Care Teams and Examining their Contribution to Hospital Length of Stay.

Walpitage D, Garcia A, Harper E, Sharma N, Waitman L AMIA Annu Symp Proc. 2020; 2019:883-892.

PMID: 32308885 PMC: 7153122.


The Role of Physician and Practice Characteristics in the Quality of Diabetes Management in Primary Care: Systematic Review and Meta-analysis.

Riordan F, McHugh S, ODonovan C, Mtshede M, Kearney P J Gen Intern Med. 2020; 35(6):1836-1848.

PMID: 32016700 PMC: 7280455. DOI: 10.1007/s11606-020-05676-7.


References
1.
Woodard L, Urech T, Landrum C, Wang D, Petersen L . Impact of comorbidity type on measures of quality for diabetes care. Med Care. 2011; 49(6):605-10. PMC: 3366691. DOI: 10.1097/MLR.0b013e31820f0ed0. View

2.
van Hateren K, Drion I, Kleefstra N, Groenier K, Houweling S, van der Meer K . A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19). BMJ Open. 2012; 2(4). PMC: 3432849. DOI: 10.1136/bmjopen-2012-001387. View

3.
Ng C, Ng K . Does practice size matter? Review of effects on quality of care in primary care. Br J Gen Pract. 2013; 63(614):e604-10. PMC: 3750799. DOI: 10.3399/bjgp13X671588. View

4.
Gulliford M, Charlton J, Latinovic R . Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion?. J Hum Hypertens. 2004; 19(2):111-7. DOI: 10.1038/sj.jhh.1001787. View

5.
Calsbeek H, Markhorst J, Voerman G, Braspenning J . Case-mix adjustment for diabetes indicators: a systematic review. Am J Manag Care. 2016; 22(2):e45-52. View